anti-KCNE2 antibody from antibodies-online

Supplier Page

Supplier Page from
antibodies-online for
anti-KCNE2 antibody

Description

Product Characteristics:
Ancillary protein that assembles as a beta subunit with a voltage-gated potassium channel complex of pore-forming alpha subunits. Modulates the gating kinetics and enhances stability of the channel complex. Associated with KCNH2/HERG is proposed to form the rapidly activating component of the delayed rectifying potassium current in heart (IKr). May associate with KCNQ2 and/or KCNQ3 and modulate the native M-type current. May associate with KCNQ1/KVLTQ1 and elicit a voltage-independent current. May associate with HCN1 and HCN2 and increase potassium current.

Synonyms: ATFB4, cardiac voltage gated potassium channel accessory subunit 2, Kcne2, KCNE2_HUMAN, LQT5, LQT6, minimum potassium ion channel related peptide 1, Minimum potassium ion channel-related peptide 1 antibody minK related peptide 1, MinK-related peptide 1, MIRP1, Potassium channel subunit beta MiRP1, potassium channel subunit, MiRP1, potassium voltage gated channel subfamily E member 2, potassium voltage gated channel, Isk related family, member 2, Potassium voltage-gated channel subfamily E member 2, voltage-gated K+ channel subunit MIRP1.

Target Information: Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium channel, voltage-gated, isk-related subfamily. This member is a small integral membrane subunit that assembles with the KCNH2 gene product, a pore-forming protein, to alter its function. This gene is expressed in heart and muscle and the gene mutations are associated with cardiac arrhythmia. [provided by RefSeq, Jul 2008]